Safety and efficacy of GZR18, a long-acting GLP-1 analog, in Chinese patients with type 2 diabetes: A randomized, double-blind, phase 1b/2a trial. (linkinghub.elsevier.com)

Authors: Liu M … Chen W Journal: Cell Reports Medicine Published: 2026-06-19 DOI: https://doi.org/10.1016/j.xcrm.2026.102874